CEO Interviews
According to a recent Gallup poll, only 29 percent of Americans say they have a "great deal" or "quite a lot of confidence" in the U.S. education system. Michelle Rhee, StudentsFirst founder and CEO, discusses the quality of public education in the United States, with radio talk show host John Batchelor. |
CNBC's Eamon Javers reports on the Washington Post's story analyzing Bain Capital's role in outsourcing jobs; and as President Obama lays out his battle plan against Romney, is the GDP getting enough attention? Jared Bernstein, former Biden chief economist; Steve Malanga, Manhattan Institute senior fellow; and Jim Garland, Sharp Details CEO, share their opinions. |
Gigantic movie house, The Weinstein Company, has just secured $225 million in financing from UBS and Union Bank. CEO Harvey Weinstein discusses how his company will use the money to grow their business, the company's overseas success, the "Intouchables," and politics. |
Insight on the market's next direction, with Christian Thwaites, Sentinel Investments, and Hank Smith, Haverford Investments. |
If you'd made a bold call and bought then, you'd actually be making money from Facebook, with Howard Lindzon, CEO of Stocktwits. |
"What we see is a cautious consumer," says Clarence Otis, Darden Restaurants CEO, discussing the slowdown in restaurant sales; the impact of rising commodities prices; and his company's "mixed" fourth quarter earnings results. |
CNBC's John Harwood reports on the details of Romney's immigration plan; and Henry Cisneros, CityView chairman & CEO; and T.J. Rodgers, Cypress Semiconductor CEO, weigh in on the presidential election and border militarization reforms. |
"I think the pipeline master limited partnerships could be a terrific place to wait out the rocky markets," says Mad Money host Jim Cramer. Kelcy Warren, Energy Transfer Partners CEO, discusses MLPs and the state of natural gas. |
Red Hat CEO James Whitehurst discusses his company's latest earnings beat and strong position in Europe. |
George Gatch, JPMorgan Asset Mgmt. Global Funds CEO, discusses what investors should be focused on at this stage of the euro zone crisis. |
Stephen Carley, Red Robin CEO, says the U.S. consumer is a bit "skittish and volatile." |
Kevin Plank, Under Armour founder & CEO, discusses the new UA Spine RPM footwear collection, with CNBC's Darren Rovell. |
Doug Oberhelman, Caterpillar chairman & CEO, offers insight on everything from the Fed, economy and dividends. |
Jack Welch, former GE chairman & CEO, shares his thoughts on the continued financial crisis in Europe; and the outlook on the U.S. economic recovery. |
"We are investing a lot of money," says Peter Evensen, Teekay Corporation CEO, discussing how his company is profiting in the shipping space, despite facing strong economic headwinds, and benefiting from the increase in liquid natural gas production. |
Ron Cohen, Acorda Therapeutics president & CEO, offers insight on just how much potential his company's multiple sclerosis drug "AMPYRA" has in the pharmaceutical market. |
Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses his company's efforts to develop treatment products for Lysosomal Storage Disorders. "We are the opposite of big pharma, we look at a significant improvement in a small patient population," says Bienaime. |
Christopher Viehbacher, Sanofi CEO, discusses his company's acquisition of Genzyme and where he sees further deals in the pharmaceutical industry. |
Insight on the Fed's meeting, with Thomas Belesis, John Thomas Financial CEO, and CNBC's Rick Santelli, Steve Liesman & Brian Shactman. |
The "Street Signs" crew and Jan Kniffen, J. Rogers Kniffen WWE CEO, discuss the recent decline in JC Penney, whether its advertising strategies reach its customers, and the departure of the company's president Michael Francis. |
Richard Pops, Alkermes CEO, says it's a good time to be developing new medicines if you have access to capital. "Biotech industry is the lifeblood-- the wells spring-- of new innovation for the big pharmaceutical companies," he says. |
John Coustas, Danaos president & CEO, discusses the slowdown in the shipping industry and what it indicates about the health of the global economy. |
Nelson Peltz, Trian Partners chairman & CEO, discusses his fund's 5.1% stake in the investment bank. |
"We are going to be the largest buyer of prescription drugs," says Gregory Wasson, Walgreen CEO, with Stefano Pessina, Alliance Boots executive chairman, discussing Walgreen's $6.7 billion deal to buy a 45 percent stake in Alliance Boots with an option to buy the rest of the company. |
Checking on the state of the U.S. economy amid the ongoing crisis in Europe and ahead of the Fed meeting, with Ron Kruszewski, Stifel Nicolaus CEO and Jack Bouroudjian, Bull and Bear Partners CEO. |
Shares of MarkWest Energy Partners are down 17% since the beginning of May, and the company's chairman & CEO Frank Semple, discusses master limited partnerships and the company's growing income from fee-based contracts. |
CNBC's Jon Fortt reports on the details of Microsoft's mystery tablet announcement; and Hans Humes, Greylock Capital president and CEO, offers insight on how to invest in European sovereign debt. |
Citigroup CEO Vikram Pandit discusses the bank's long, restructuring project, with CNBC's Maria Bartiromo. "Where we are today, we think we're sized well for this environment," he says. |
Vikram Pandit, Citigroup CEO, discusses the bank's restructuring, Europe and more. |
Vikram Pandit, Citigroup CEO, discusses the outlook on the banking giant as it enters its third century and where he sees rebound in the housing market. |